中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

慢性胆管炎伴间质黏液变性误诊为胆管癌1例报告

范松松 张芳 杨立鹏 曹学峰 卢艳敏 张兴元

引用本文:
Citation:

慢性胆管炎伴间质黏液变性误诊为胆管癌1例报告

DOI: 10.3969/j.issn.1001-5256.2022.07.031
基金项目: 

山东省自然科学基金项目 (ZR2015HL084)

伦理学声明:本报告已获得患者知情同意。
利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:范松松、张芳、杨立鹏、曹学峰、卢艳敏、张兴元负责查阅文献并拟定写作思路; 范松松、张芳、杨立鹏、曹学峰负责资料分析; 范松松、张芳、张兴元负责论文写作与修改。
详细信息
    通信作者:

    张兴元,byfyzxy@163.com

Chronic cholangitis with interstitial mucinous degeneration misdiagnosed as cholangiocarcinoma: A case report

Research funding: 

Nature Science Foundation of Shandong Province (ZR2015HL084)

More Information
    Corresponding author: ZHANG Xingyuan, byfyzxy@163.com(ORCID: 0000-0002-7405-3805)
  • 图  1  影像学检查

    注:a,CT提示肝总管、胆囊管及胆总管交界区偏心性增厚伴近端胆管扩张; b,MRCP表现为肝总管、胆囊管及胆总管交界区狭窄,梗阻近端胆系扩张。

    Figure  1.  Image analysis

    图  2  HE染色及免疫组化结果(×200)

    注:a,HE染色提示慢性胆管炎伴间质黏液变性; b,免疫组化分析示CD68(+); c,免疫组化分析示CD20(+); d,免疫组化分析示CD3(+)。

    Figure  2.  HE staining and immunohistochemistry(×200)

  • [1] RIZVI S, KHAN SA, HALLEMEIER CL, et al. Cholangiocarcinoma-evolving concepts and therapeutic strategies[J]. Nat Rev Clin Oncol, 2018, 15(2): 95-111. DOI: 10.1038/nrclinonc.2017.157.
    [2] GAO B, ZHAO HY. Progress in the epidemiological characteristics and risk factors of intrahepatic cholangiocarcinoma[J]. J Mod Oncol, 2020, 28(7): 1214-1217. DOI: 10.3969/j.issn.1672-4992.2020.07.037.

    高博, 赵海鹰. 肝内胆管癌的流行病学特征及危险因素研究进展[J]. 现代肿瘤医学, 2020, 28(7): 1214-1217. DOI: 10.3969/j.issn.1672-4992.2020.07.037.
    [3] KHAN SA, TAVOLARI S, BRANDI G. Cholangiocarcinoma: Epidemiology and risk factors[J]. Liver Int, 2019, 39(Suppl 1): 19-31. DOI: 10.1111/liv.14095.
    [4] SCHIZAS D, MASTORAKI A, ROUTSI E, et al. Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management[J]. Hepatobiliary Pancreat Dis Int, 2020, 19(6): 515-523. DOI: 10.1016/j.hbpd.2020.07.004.
    [5] PU T, FANG Q, CHEN ZX, et al. Advances in molecular pathogenesis and treatment of intrahepatic cholangiocarcinoma[J]. Chin J Dig Surg, 2020, 19(6): 697-702. DOI: 10.3760/cma.j.cn115610-20200504-00325.

    濮天, 方强, 陈子祥, 等. 肝内胆管癌发病机制及治疗相关进展[J]. 中华消化外科杂志, 2020, 19(6): 697-702. DOI: 10.3760/cma.j.cn115610-20200504-00325.
    [6] SHEN H, XIA Y, CHEN YB, et al. Risk factors analysis of intrahepatic cholangiocarcinoma after hepatectomy for hepatolithiasis[J]. Chin J Dig Surg, 2020, 19(8): 835-842. DOI: 10.3760/cma.j.cn115610-20200531-00402.

    沈皓, 夏勇, 陈玉宝, 等. 肝内胆管结石肝切除术后发生肝内胆管癌的危险因素分析[J]. 中华消化外科杂志, 2020, 19(8): 835-842. DOI: 10.3760/cma.j.cn115610-20200531-00402.
    [7] LI L, LIU H, SONG WY. Analysis of the clinical characteristics and diagnosis and treatment process of IgG4-related sclerosing cholangitis[J]. J Clin Hepatol, 2021, 37(8): 1883-1887. DOI: 10.3969/j.issn.1001-5256.2021.08.026.

    李丽, 刘晖, 宋文艳. IgG4相关硬化性胆管炎临床特征及诊疗过程分析[J]. 临床肝胆病杂志, 2021, 37(8): 1883-1887. DOI: 10.3969/j.issn.1001-5256.2021.08.026.
    [8] RIZVI S, GORES GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma[J]. Gastroenterology, 2013, 145(6): 1215-1229. DOI: 10.1053/j.gastro.2013.10.013.
    [9] DOHERTY B, NAMBUDIRI VE, PALMER WC. Update on the diagnosis and treatment of cholangiocarcinoma[J]. Curr Gastroenterol Rep, 2017, 19(1): 2. DOI: 10.1007/s11894-017-0542-4.
    [10] MA WJ, SHRESTHA A, LI FY. Is intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma of limited value?[J]. Cancer Med, 2016, 5(10): 2848-2849. DOI: 10.1002/cam4.920.
    [11] MACIAS R, KORNEK M, RODRIGUES PM, et al. Diagnostic and prognostic biomarkers in cholangiocarcinoma[J]. Liver Int, 2019, 39(Suppl 1): 108-122. DOI: 10.1111/liv.14090.
    [12] WANG TL, WU G. Progress in diagnosis and treatment of IgG4 associated sclerosing cholangitis[J]. Chin J Gerontol, 2021, 41(14): 3145-3148. DOI: 10.3969/j.issn.1005-9202.2021.14.063.

    王天龙, 吴刚. IgG4相关硬化性胆管炎的诊治进展[J]. 中国老年学杂志, 2021, 41(14): 3145-3148. DOI: 10.3969/j.issn.1005-9202.2021.14.063.
    [13] XIAO J, LI G, YANG G, et al. Case report: A female case of isolated IgG4-related sclerosing cholangitis mimicking cholangiocarcinoma[J]. Medicine(Baltimore), 2017, 96(16): e6542. DOI: 10.1097/MD.0000000000006542.
    [14] TANAKA A. IgG4-related sclerosing cholangitis and primary sclerosing cholangitis[J]. Gut Liver, 2019, 13(3): 300-307. DOI: 10.5009/gnl18085.
    [15] LLEO A, MARZORATI S, ANAYA JM, et al. Primary biliary cholangitis: a comprehensive overview[J]. Hepatol Int, 2017, 11(6): 485-499. DOI: 10.1007/s12072-017-9830-1.
    [16] NGUYEN CANH H, HARADA K. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma[J]. Med Mol Morphol, 2016, 49(4): 189-202. DOI: 10.1007/s00795-016-0143-6.
    [17] MA MX, JAYASEKERAN V, CHONG AK. Benign biliary strictures: Prevalence, impact, and management strategies[J]. Clin Exp Gastroenterol, 2019, 12: 83-92. DOI: 10.2147/CEG.S165016.
    [18] LIANG BY, HUANG ZY, ZHANG ZY, et al. Etiology, diagnosis and treatment of benign hepatic portal biliary stenosis[J]. J Abdom Surg, 2016, 29(5): 327-330. DOI: 10.3969/j.issn.1003-5591.2016.05.003.

    梁宾勇, 黄志勇, 张尊义, 等. 肝门部胆管良性狭窄的病因、诊断及治疗[J]. 腹部外科, 2016, 29(5): 327-330. DOI: 10.3969/j.issn.1003-5591.2016.05.003.
    [19] TANG ZW, MENG WB, LI X. Status and controversy of preoperative diagnosis and bile duct cholangiocarcinoma drainage strategy[J]. J Lanzhou Univ, 2019, 45(2): 67-74. DOI: 10.13885/j.issn.1000-2812.2019.02.012.

    唐增伟, 孟文勃, 李汛. 肝门部胆管癌术前诊断及胆道引流策略的现状与争议[J]. 兰州大学学报, 2019, 45(2): 67-74. DOI: 10.13885/j.issn.1000-2812.2019.02.012.
    [20] XU W, MIAO L, WANG ZF, et, al. Application of SpyGlass TM DS in diagnosis and treatment of biliary diseases[J]. J Clin Hepatol, 2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052.

    徐雯, 苗龙, 王正峰, 等. SpyGlass TM DS直视化系统在胆道疾病诊疗中的应用[J]. 临床肝胆病杂志, 2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052.
    [21] ZHANG GJ, ZHANG DY, CAI FC, et al. New development of endoscopic retrograde cholangiopancreatography in the diagnosis and treatment[J/CD]. Chin J Gastrointestinal Endosc(Electronic Edition), 2020, 7(4): 205-210. DOI: 10.3877/cma.j.issn.2095-7157.2020.04.008.

    张贯军, 张大涯, 蔡逢春, 等. 内镜逆行胰胆管造影术诊治新进展[J/CD]. 中华胃肠内镜电子杂志, 2020, 7(4): 205-210. DOI: 10.3877/cma.j.issn.2095-7157.2020.04.008.
    [22] TAGHAVI SA, ESHRAGHIAN A, NIKNAM R, et al. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis[J]. Expert Rev Gastroenterol Hepatol, 2018, 12(6): 575-584. DOI: 10.1080/17474124.2018.1473761.
  • 加载中
图(2)
计量
  • 文章访问数:  640
  • HTML全文浏览量:  210
  • PDF下载量:  26
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-09-02
  • 录用日期:  2021-10-25
  • 出版日期:  2022-07-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回